Navigation Links
Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain
Date:10/6/2008

on, anterior chamber cells, anterior chamber flare, conjunctival edema, and blepharitis. Other ocular adverse reactions occurring in 1-5% of patients included reduced visual acuity, punctate keratitis, eye inflammation, and iritis. Ocular adverse events occurring in < 1% of patients included application site discomfort or irritation, corneal pigmentation and striae, episcleritis, eye pruritis, eyelid irritation and crusting, foreign body sensation, increased lacrimation, macular edema, scleral hyperemia, and uveitis. Most of these events may have been the consequence of the surgical procedure.

About Sirion Therapeutics, Inc.

Sirion Therapeutics is a privately held biopharmaceutical company pursuing the discovery, development, and commercialization of products addressing unmet medical needs in the protection and preservation of eyesight. Sirion's diverse product portfolio includes products that address ocular diseases and conditions including uveitis, herpetic keratitis, dry eye, and geographic atrophy associated with dry AMD. For more information, please visit http://www.siriontherapeutics.com.


'/>"/>
SOURCE Sirion Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Video: New Research Discovers Independent Brain Networks Control Human Walking
2. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
3. Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies
4. Video: Actress and New Mom Keri Russell Joins PKIDs to Launch Silence the Sounds of Pertussis Campaign
5. Video: Quest Diagnostics Health Trends(TM) Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease
6. Video: New Results From One of the Worlds Largest Breast Cancer Trials Herald Hope for Thousands of Women
7. VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy
8. Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics Heart Health Test
9. Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer
10. Video: Clinical Study Shows Liraglutide Reduced Blood Sugar, Weight, and Blood Pressure in Patients with Type 2 Diabetes
11. Video: Sanford Healths Journey to Cure Type 1 Diabetes Receives Major Boost
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... International Isotopes Inc. (OTCQB: INIS) (the "Company") ... 31, 2014.  The Company reports a 10% increase in ... cash flow for the year ended December 31, 2014. ... approximately $7.5 million compared to approximately $6.8 million in ... the exception of the radiological services segment, our three ...
(Date:4/1/2015)... , April 1, 2015 ... Report on Global Azithromycin Industry and 2015 ... Industry reports added to Pharmaceutical category in ... the report introduces Azithromycin basic information, including ... overview, policy analysis, and news analysis, etc. ...
(Date:4/1/2015)... Oramed Pharmaceuticals Inc. (NASDAQ: ... focused on the development of oral drug delivery systems, ... its Glucose Clamp Study. The study will be performed ... San Antonio and University Health ... Ralph DeFronzo . The glucose clamp ...
Breaking Medicine Technology:International Isotopes Inc. Announces 2014 Year End Financial Results 2International Isotopes Inc. Announces 2014 Year End Financial Results 3International Isotopes Inc. Announces 2014 Year End Financial Results 4International Isotopes Inc. Announces 2014 Year End Financial Results 5International Isotopes Inc. Announces 2014 Year End Financial Results 6International Isotopes Inc. Announces 2014 Year End Financial Results 7Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 2Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 3Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 4Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 5Oramed Enrolls First Patient in its Glucose Clamp Study for Oral Insulin 2Oramed Enrolls First Patient in its Glucose Clamp Study for Oral Insulin 3
(Date:4/1/2015)... Dallas, Texas (PRWEB) April 01, 2015 ... surgeon and Distinguished Teaching Professor of the Department ... joined with other doctors to review reports of blindness ... in cosmetic surgery . The group published their study, ... Plastic and Reconstructive Surgery journal. , "We began to ...
(Date:4/1/2015)... The 2015 Deep Market Research Report ... and in-depth study on the current state of ... a focus on the Chinese situation. , Major ... Pfizer, Lek Pharmaceuticals D.D., Dr Reddys Labs Ltd, ... Cadila Healthcare Limited, Sandoz Inc, Teva Pharms, Apotex ...
(Date:4/1/2015)... D.C. (PRWEB) April 01, 2015 It is ... solely for breakfast but now found wrapped around other foods, ... Bacon has been called meat candy, the gateway meat for ... a cultural icon, the North American Meat Institute (NAMI) has ... a video tour of a bacon processing plant ...
(Date:4/1/2015)... ScooterDirect.com is a one stop online store that provides ... using electric mobility scooters, power chairs and portable carts. ... they provide mobility scooters at an affordable price. They ... freedom. Scooterdirect.com is offering Pride Go Go Traveller Elite ... One of the team members quoted, “Pride Go Go ...
(Date:4/1/2015)... Phybridge Inc., a provider of ... its strategic partnership with SaskTel in a joint ... businesses of Saskatchewan. SaskTels’ Integrated Business Communications (IBC) ... offers users a hosted IP unified communications solution ... objective of IBC is to offer an end-to-end ...
Breaking Medicine News(10 mins):Health News:Dr. Rod J. Rohrich and Colleagues Study Rare Occurrences of Blindness Caused by Use of Facial Fillers 2Health News:Dr. Rod J. Rohrich and Colleagues Study Rare Occurrences of Blindness Caused by Use of Facial Fillers 3Health News:Atorvastatin Calcium Industry International & China Market Analysis 2015-2020 2Health News:Atorvastatin Calcium Industry International & China Market Analysis 2015-2020 3Health News:New Ultimate Guide to Bacon Video Provides Inside Look at How Bacon is Made 2Health News:ScooterDirect.com Offering Pride Go Go Traveller Elite 3 Wheel Scooter 2Health News:Phybridge and SaskTel Team Up to Eliminate Network Barriers for IP Telephony and Unified Communications Migration 2Health News:Phybridge and SaskTel Team Up to Eliminate Network Barriers for IP Telephony and Unified Communications Migration 3
... team effort, the best qualities of two drugs commonly prescribed ... medicines alone, according to a new study from UT Southwestern ... of the journal European Urology , compared treatments for ... years. The study, which included more than 4,800 men, is ...
... ... , ... March 2, 2010 -- Strategic Connections Inc., provider of the leading integrated communications and ... brand, including the "Strategic Connections" corporate name, a new logo, and a new url. ...
... ... the Adaptive Business Leaders Organization (ABL)’s 2010 “Leadership in Innovation” Award and make the ... in Newport Beach, California. , ... Santa Ana, CA (PRWEB) March 2, 2010 -- Debra Reisenthel, President and ...
... ... ... ... ...
... ... ... , ... , ...
... new study is providing insight into how estrogen fuels many ... new cancer-fighting drugs. Researchers found that estrogen inhibits a ... leads to uncontrolled growth of cancer cells and resistance to ... other centers reported the findings in the journal Cancer ...
Cached Medicine News:Health News:Combination therapy more effective for enlarged prostate 2Health News:Strategic Connections Inc. (SCI) Announces Market Expansion and New Brand 2Health News:Strategic Connections Inc. (SCI) Announces Market Expansion and New Brand 3Health News:Novasys Medical's Debra Reisenthel Named ABL's 2010 &#8220;Leadership in Innovation&#8221; Awardee 2Health News:Novasys Medical's Debra Reisenthel Named ABL's 2010 &#8220;Leadership in Innovation&#8221; Awardee 3Health News:President Obama Gets Virtual Colonoscopy (CT Colonography) But Medicare Denies CTC Coverage to Seniors 2Health News:President Obama Gets Virtual Colonoscopy (CT Colonography) But Medicare Denies CTC Coverage to Seniors 3Health News:President Obama Gets Virtual Colonoscopy (CT Colonography) But Medicare Denies CTC Coverage to Seniors 4Health News:President Obama Gets Virtual Colonoscopy (CT Colonography) But Medicare Denies CTC Coverage to Seniors 5Health News:President Obama Gets Virtual Colonoscopy (CT Colonography) But Medicare Denies CTC Coverage to Seniors 6Health News:Nemours Data Show Childhood Overweight and Obesity Leveling Off in Delaware 2Health News:Nemours Data Show Childhood Overweight and Obesity Leveling Off in Delaware 3Health News:Nemours Data Show Childhood Overweight and Obesity Leveling Off in Delaware 4Health News:Nemours Data Show Childhood Overweight and Obesity Leveling Off in Delaware 5
... Basic ergonomic chairs with concave ... support • Select options like seats, ... • BTP/1Q-PAL chairs are recommended for ... clean room, static control, health care ...
... concave seats and standard-sized backrests with ... seats, backrests, armrests, and casters and ... for the following environments: industry, education, ... care and office. • With polished ...
... concave seats and standard-sized backrests with ... seats, backrests, armrests, and casters and ... for the following environments: industry, education, ... care and office. • With polished ...
... ergonomic chairs with concave seats and ... Select options like seats, backrests, armrests, ... chairs are recommended for the following ... static control, health care and office. ...
Medicine Products: